A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells

By Sato Takashi   Watanabe Mami   Hashimoto Kei   Ota Tomoko   Akimoto Noriko   Imada Keisuke   Nomizu Motoyoshi   Ito Akira  

International Journal of Oncology, Vol. 40, Iss. 1, 2012-01 ,pp. : 236-242

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

By Davidson Ben   Givant-Horwitz Vered   Lazarovici Philip   Risberg Björn   Nesland Jahn   Trope Claes   Schaefer Erik   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 20, Iss. 7, 2003-11 ,pp. : 621-631

Springer Publishing Company

Access to resources Recommend Favorite

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

By Davidson Ben   Goldberg Iris   Berner Aasmund   Kristensen Gunnar   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 20, Iss. 2, 2003-03 ,pp. : 161-169

Springer Publishing Company

Access to resources Recommend Favorite

Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer

By          

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 342-348

Spandidos Publications

Access to resources Recommend Favorite

Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor2 protein expression in papillary thyroid carcinoma using a quantum dotbased immunofluorescence technique

By    

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1331-1335

Spandidos Publications

Access to resources Recommend Favorite